US 10876116
Anti-ARID3a treatments for inflammatory disorders
granted A61PA61P31/12A61P37/02
Quick answer
US patent 10876116 (Anti-ARID3a treatments for inflammatory disorders) held by The Board of Regents of the University of Oklahoma expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P31/12, A61P37/02